Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Berchuck

Showing results (101-110 of 372) with videos related to

Pageof 38
Sort By:
Molecular Cancer Research : MCR|April 11, 2006
Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancerSusan K Murphy, Zhiqing Huang, Yaqing Wen, et al.
Gynecologic Oncology|July 15, 2011
Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancerDeanna Teoh, Andrew Berchuck, Angeles Alvarez Secord, et al.
International Journal of Cancer|October 2, 2009
Targeting slow-proliferating ovarian cancer cellsEiji Kondoh, Seiichi Mori, Ken Yamaguchi, et al.
Molecular Cancer Therapeutics|October 10, 2020
Targeting Dormant Ovarian Cancer Cells <i>In Vitro</i> and in an <i>In Vivo</i> Mouse Model of Platinum ResistanceZhiqing Huang, Eiji Kondoh, Zachary R Visco, et al.
Cancer|July 23, 2003
A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinomaEllen L Jones, Thaddeus V Samulski, Mark W Dewhirst, et al.
Frontiers in Oncology|April 8, 2021
Epigenetic Regulation of Claudin-1 in the Development of Ovarian Cancer Recurrence and Drug ResistanceZachary R Visco, Gregory Sfakianos, Carole Grenier, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2022
Healthcare Access Domains Mediate Racial Disparities in Ovarian Cancer Treatment Quality in a US Patient Cohort: A Structural Equation Modelling AnalysisTomi Akinyemiju, Quan Chen, Lauren E Wilson, et al.
Neuro-Oncology Advances|June 15, 2022
Pleiotropic <i>MLLT10</i> variation confers risk of meningioma and estrogen-mediated cancersKyle M Walsh, Chenan Zhang, Lisa Calvocoressi, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 7, 2006
Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinomaEllen Jones, Angeles Alvarez Secord, Leonard R Prosnitz, et al.
Gynecologic Oncology|December 17, 2009
Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotypeJason C Barnett, Sarah M Bean, Regina S Whitaker, et al.
Pageof 38

Showing results (101-110 of 372) with videos related to

Sort By:
Pageof 38
Molecular Cancer Research : MCR|April 11, 2006
Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancerSusan K Murphy, Zhiqing Huang, Yaqing Wen, et al.
Gynecologic Oncology|July 15, 2011
Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancerDeanna Teoh, Andrew Berchuck, Angeles Alvarez Secord, et al.
International Journal of Cancer|October 2, 2009
Targeting slow-proliferating ovarian cancer cellsEiji Kondoh, Seiichi Mori, Ken Yamaguchi, et al.
Molecular Cancer Therapeutics|October 10, 2020
Targeting Dormant Ovarian Cancer Cells <i>In Vitro</i> and in an <i>In Vivo</i> Mouse Model of Platinum ResistanceZhiqing Huang, Eiji Kondoh, Zachary R Visco, et al.
Cancer|July 23, 2003
A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinomaEllen L Jones, Thaddeus V Samulski, Mark W Dewhirst, et al.
Frontiers in Oncology|April 8, 2021
Epigenetic Regulation of Claudin-1 in the Development of Ovarian Cancer Recurrence and Drug ResistanceZachary R Visco, Gregory Sfakianos, Carole Grenier, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2022
Healthcare Access Domains Mediate Racial Disparities in Ovarian Cancer Treatment Quality in a US Patient Cohort: A Structural Equation Modelling AnalysisTomi Akinyemiju, Quan Chen, Lauren E Wilson, et al.
Neuro-Oncology Advances|June 15, 2022
Pleiotropic <i>MLLT10</i> variation confers risk of meningioma and estrogen-mediated cancersKyle M Walsh, Chenan Zhang, Lisa Calvocoressi, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 7, 2006
Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinomaEllen Jones, Angeles Alvarez Secord, Leonard R Prosnitz, et al.
Gynecologic Oncology|December 17, 2009
Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotypeJason C Barnett, Sarah M Bean, Regina S Whitaker, et al.
Pageof 38